N. P. Jivani

Bio: N. P. Jivani is an academic researcher from C.U.Shah University. The author has contributed to research in topics: Kidney & Renal ischemia. The author has an hindex of 9, co-authored 25 publications receiving 253 citations. Previous affiliations of N. P. Jivani include Jodhpur National University.

Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide.

Abstract: Background/Aim: This study was designed to investigate the possible effect of exenatide (Glucagon like Peptide-1 receptor agonist) on liver injury (distant organ) induced by renal ischemia reperfusion (IR) in diabetic rats. Materials and Methods: In vivo renal IR was performed in both type 2 diabetic and normal rats. Each protocol comprised ischemia for 30 minutes followed by reperfusion for 24 hours and a treatment period of 14 days before induction of ischemia. Results: Lipid peroxidation, xanthine oxidase activity, myeloperoxidase activity and nitric oxide level in liver tissue were significantly increased (P < 0.01, P < 0.001, P < 0.001, P < 0.05, respectively), after IR in diabetic rats compared to normal rats. Antioxidant enzymes like glutathione, superoxide dismutase, catalase and glutathione peroxidase were significantly reduced (P < 0.05, P < 0.05, P < 0.01, P < 0.05, respectively), after IR in diabetic rats compared to normal rats. Exenatide treatment significantly normalized (P < 0.01), these biochemical parameters in treated rats compared to diabetic IR rats. Serum creatinine phosphokinase activity and liver function enzymes were also significantly normalized (P < 0.001, P < 0.001, respectively), after administration of exenatide. Conclusion: Exenatide exerted protective effect on exaggerated remote organ (liver) injury induced by renal IR in diabetes.

Comparative evaluation of alcoholic and aqueous extracts of ocimum sanctum for immunomodulatory activity

Abstract: Background: Traditionally the aqueous and alcoholic extracts as well as seed oil of Ocimum sanctum is reported to modulate the immune response. So the present study was undertaken to compare the immunomodulatory activity between alcoholic and aqueous extract of Ocimum sanctum. Objective: To comparatively evaluate the immunomodulatory activity of alcoholic and aqueous extracts of Ocimum sanctum. Methods: Alcoholic and aqueous extracts of Ocimum sanctum were administered orally at doses of 50, 100 and 200 mg/kg/day for 14 days to healthy albino Swiss mice. The assessment of immunomodulatory activity was carried by testing the humoral (haemagglutination antibody titer model) and cellular immunity (delayed type hypersensitivity reaction models). Results: On oral administration of aqueous and alcoholic extracts had stimulatory effect on delayed type hypersensitivity (DTH) and significantly (p<0.01) improved humoral immunity. Conclusion: The study shown stimulatory effect on the humoral and delayed type hypersensitivity but the alcoholic extract was more potent in producing immune stimulation than aqueous extract.

Renoprotective activity of benincasa cerifera fruit extract on ischemia/reperfusion-induced renal damage in rat

Abstract: Introduction. Evidence suggests that reactive oxygen species play a role in the pathophysiology of renal ischemia/reperfusion (I/R) injury. This study was designed to investigate the renoprotective activity of methanolic fruit extract of Benincasa cerifera in I/Rinduced kidney failure in rats. Materials and Methods. Renal pedicles of 12 rats were occluded for 60 minutes followed by 24 hours of reperfusion. Six days prior to induction of I/R, 6 of the rats received Benincasa cerifera, 500 mg/kg, orally. Serum creatinine, urea, and uric acid levels were measured after the operation. At the end of reperfusion period, the rats were sacrificed. Superoxide dismutage, catalase, reduced glutathione, and renal malondialdehyde content were determined in the renal tissues. Results were compared with a group of rats with sham operation. Results. Renal I/R caused significant impairment of kidney function. Six-day administration of Benincasa cerifera, however, minimized this effect. Rats with renal I/R only showed significantly decreased activity of superoxide dismutage, catalase, and reduced glutathione compared with the sham-operated rats. These declining trends were significantly less in the group treated with Benincasa cerifera compared with those in the I/R-only group (P = .008, P = .07, and P < .001, respectively). Renal I/R produced a significant increase in malondialdehyde level, while pretreatment with Benincasa cerifera was associated with a significantly lower malondialdehyde level (P < .001). Conclusions. These findings imply that reactive oxygen species play a crucial role in I/R-induced kidney injury and Benincasa cerifera exerts renoprotective activity probably by the radical scavenging activity.

Phytopharmacological Properties of Bambusa arundinacea as a Potential Medicinal Tree: An Overview

Abstract: Bambusa arundinacea family Graminae is highly reputed ayurvedic medicinal tree commonly known as the Bamboo. It is tall sized tree growing throughout India, moist parts of India. It also occurs in Sri Lanka, Malaya, Peru and Myanmar. The different parts of this plant contain silica, Cholin, betain, cynogenetic glycosides, albuminoids, Oxalic acid, reducing sugar, resins, waxes, benzoic acid, Arginine, cysteine, histidine, niacin, riboflavin, thiamine, Protein, gluteline, contains lysine, methionine, betain, cholin, proteolytic enzyme, nuclease, urease. Various parts of this plant such as Leaf, root, shoot and seed possess Anti-inflammatory, Antiulcer, Anti-diabetic, Anti-oxidant, anthelmintic, astringent, emmengogue activity. Various phytopharmacological evaluations have been reported in this literature for the important potential of the Bambusa arundinacea.

Cataract: A major secondary diabetic complication

Abstract: Cataract is a visual impairment occurs due to the opacification of crystalline lens. It affects around 17 billion peoples worldwide, although incidence of cataracts is increasing day by day among the elderly persons. Still today except surgery no other effective treatment have been successfully developed so far, thus this present review is focused to highlights the etiological aspects, risk factors along with possible pharmacological prevention and animal models which are widely used for screening anticataract activity. The present review includes the list of plants and their phytoconstituents which have been evaluated pharmacologically for the treatment of cataract. From the review it can be concluded that antioxidant properties of plants phytochemicals are responsible for the anticataract activity. DOI: http://dx.doi.org/10.3329/icpj.v1i7.10813 International Current Pharmaceutical Journal 2012, 1(7): 180-185

Cell Biology of Ischemia/Reperfusion Injury

Abstract: Disorders characterized by ischemia/reperfusion (I/R), such as myocardial infarction, stroke, and peripheral vascular disease, continue to be among the most frequent causes of debilitating disease and death. Tissue injury and/or death occur as a result of the initial ischemic insult, which is determined primarily by the magnitude and duration of the interruption in the blood supply, and then subsequent damage induced by reperfusion. During prolonged ischemia, ATP levels and intracellular pH decrease as a result of anaerobic metabolism and lactate accumulation. As a consequence, ATPase-dependent ion transport mechanisms become dysfunctional, contributing to increased intracellular and mitochondrial calcium levels (calcium overload), cell swelling and rupture, and cell death by necrotic, necroptotic, apoptotic, and autophagic mechanisms. Although oxygen levels are restored upon reperfusion, a surge in the generation of reactive oxygen species occurs and proinflammatory neutrophils infiltrate ischemic tissues to exacerbate ischemic injury. The pathologic events induced by I/R orchestrate the opening of the mitochondrial permeability transition pore, which appears to represent a common end-effector of the pathologic events initiated by I/R. The aim of this treatise is to provide a comprehensive review of the mechanisms underlying the development of I/R injury, from which it should be apparent that a combination of molecular and cellular approaches targeting multiple pathologic processes to limit the extent of I/R injury must be adopted to enhance resistance to cell death and increase regenerative capacity in order to effect long-lasting repair of ischemic tissues.

Long-Term Risk of Coronary Events after AKI

Abstract: The incidence rate of AKI in hospitalized patients is increasing. However, relatively little attention has been paid to the association of AKI with long-term risk of adverse coronary events. Our study investigated hospitalized patients who recovered from de novo dialysis-requiring AKI between 1999 and 2008 using patient data collected from inpatient claims from Taiwan National Health Insurance. We used Cox regression with time-varying covariates to adjust for subsequent CKD and ESRD after discharge. Results were further validated by analysis of a prospectively constructed database. Among 17,106 acute dialysis patients who were discharged, 4869 patients recovered from dialysis-requiring AKI (AKI recovery group) and were matched with 4869 patients without AKI (non-AKI group). The incidence rates of coronary events were 19.8 and 10.3 per 1000 person-years in the AKI recovery and non-AKI groups, respectively. AKI recovery associated with higher risk of coronary events (hazard ratio [HR], 1.67; 95% confidence interval [95% CI], 1.36 to 2.04) and all-cause mortality (HR, 1.67; 95% CI, 1.57 to 1.79) independent of the effects of subsequent progression to CKD and ESRD. The risk levels of de novo coronary events after hospital discharge were similar in patients with diabetes alone and patients with AKI alone (P=0.23). Our results reveal that AKI with recovery associated with higher long-term risks of coronary events and death in this cohort, suggesting that AKI may identify patients with high risk of future coronary events. Enhanced postdischarge follow-up of renal function of patients who have recovered from temporary dialysis may be warranted.